FLGT - CIK 0001674930
Fulgent Genetics, Inc. (FLGT) reported revenue of $322.67M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $322.67M | +13.8% |
| FY 2024 | $283.47M | -2.0% |
| FY 2023 | $289.21M | -53.3% |
| FY 2022 | $618.97M | -37.6% |
| FY 2021 | $992.58M | +135.4% |
| FY 2020 | $421.71M | +1196.5% |
| FY 2019 | $32.53M | +52.3% |
| FY 2018 | $21.35M | +14.0% |
| FY 2017 |
Fulgent Genetics, Inc. (FLGT) reported revenue of $322.67M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2014 and fiscal 2025, Fulgent Genetics, Inc.'s revenue grew from $1.28M to $322.67M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $18.73M |
| +2.5% |
| FY 2016 | $18.28M | +90.9% |
| FY 2015 | $9.58M | +649.3% |
| FY 2014 | $1.28M | - |